3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
5
Urothelial Carcinoma of the Bladder
1
Rhabdoid Tumor
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Choroid Plexus Neoplasms
1
Childhood Solid Tumor
1
Central Nervous System Neoplasms
1
Interventions
Letrozole
25
Fulvestrant
25
Specimen Handling
19
ribociclib
16
Capecitabine
16
pembrolizumab
14
palbociclib
14
Paclitaxel
14
Trastuzumab
13
Carboplatin
13
exemestane
12
abemaciclib
12
Tamoxifen
12
Anastrozole
12
Magnetic Resonance Spectroscopy
11
trastuzumab deruxtecan
8
pertuzumab
8
Biopsy
8
Goserelin
7
inavolisib
6
giredestrant
6
Cyclophosphamide
6
130-nm albumin-bound paclitaxel
6
patritumab deruxtecan
5
eribulin
5
elacestrant
5
Taxes
5
Standard of Care
5
Radiotherapy
5
Gonadotropin-Releasing Hormone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Vinblastine
×
30 days
×
Clear all
No trials found.